Association of the Köbner Phenomenon With Disease Activity and Therapeutic Responsiveness in Vitiligo Vulgaris

Njoo, M. D.; Das, Pranab K.; Bos, J. D.; Westerhof, W.

doi:10.1001/archderm.135.4.407

Cited by 211 publications

(188 citation statements)

References 23 publications

(25 reference statements)

Supporting

Mentioning

186

Contrasting

Unclassified

Order By: Relevance

“…Treatment efficacy was evaluated after treatment by the changes in the affected areas with the calculation of the percentage of repigmentation. In addition, activity of the disease in all patients before and after treatment was evaluated by VIDA index [12].…”

Section: Methodsmentioning

confidence: 99%

Treatment of Non-Segmental Vitiligo with Narrowband UVB Phototherapy (311 Nm): Clinical Efficacy and Mechanisms of Action

Прошутинская¹

2014

J Clin Exp Dermatol Res

View full text Add to dashboard Cite

Section: Methodsmentioning

confidence: 99%

Treatment of Non-Segmental Vitiligo with Narrowband UVB Phototherapy (311 Nm): Clinical Efficacy and Mechanisms of Action

Прошутинская¹

2014

J Clin Exp Dermatol Res

View full text Add to dashboard Cite

“…Scores over one refer to that the disease is active in different time period in a year. Score of zero refers to stable over a year [11]. Data on serum HSV Ab screening tests for 724 pregnancy women were used as a sero-prevalence control.…”

Section: Methodsmentioning

confidence: 99%

No Evidence of HSV Presence in the Serum of Vitiligo Patients

Liu¹,

Qi²

2014

Pigmentary Disorders

View full text Add to dashboard Cite

Vitiligo is mostly regarded as a consequence of autoimmune response, while the triggering factors remain to be determined. We checked the presence of HSV specific DNA, and IgG and IgM antibodies against HSV, in serum of 90 vitiligo patients by PCR and chemiluminescence methods, respectively. No HSV specific DNA was detected in vitiligo of any types or stages. The seropositivity of antibodies against HSV was similar between the patients and controls. Other approaches should be tried to clarify the role of HSV in the pathogenesis of vitiligo.

show abstract

“…It is suggested that surgery may be performed only in patients with VIDA scores of -1 or 0 (Table 2). 12 Before performing any surgical treatment, it is necessary to perform a minigraft test.…”

Section: Classificationmentioning

confidence: 99%

Surgical management of vitiligo - An approach to the patient

Manchanda

Bansal

Pandey

2013

Nepal J Dermatol Venereol & Leprol

View full text Add to dashboard Cite

Vitiligo vulgaris is an acquired chronic pigmentary disorder with an average world wide incidence of approximately 1%. Clinical classification of vitiligo is based on the distribution and extension of lesions as localized, generalized, and universal. As vitiligo has great psychosocial implications especially in dark-skinned individuals, treatment should begin early. Currrent modalities of treatment include medical therapy, surgical modalities and laser. Medical treatment options include topical corticosteroids, calcineurin inhibitors, vitamin-D derivatives, phototherapy (ultraviolet A [UVA], narrowband UVB), photochemotherapy (psoralen plus UVA [PUVA]. Surgical methods used in the management of vitiligo gave cosmetically acceptable results in short periods. Successful treatment with various surgical techniques requires an appropriate selection of patients mainly focusing upon the stability of the clinical disease. The choice of the procedure always depends upon the age, the area involved, site and the cosmetic need of the patient. The nature of the procedure, expected outcome and the complications should be discussed with the patient in detail. This article mainly deals with various dermatosurgical approaches in brief available till date for the treatment of vitiligo.

show abstract

Association of the Köbner Phenomenon With Disease Activity and Therapeutic Responsiveness in Vitiligo Vulgaris

Cited by 211 publications

References 23 publications

Treatment of Non-Segmental Vitiligo with Narrowband UVB Phototherapy (311 Nm): Clinical Efficacy and Mechanisms of Action

Treatment of Non-Segmental Vitiligo with Narrowband UVB Phototherapy (311 Nm): Clinical Efficacy and Mechanisms of Action

No Evidence of HSV Presence in the Serum of Vitiligo Patients

Surgical management of vitiligo - An approach to the patient

Contact Info

Product

Resources

About